Hints and tips:
...focused Novartis”....
...face price negotiations includes a diabetes pill called Jardiance sold by Boehringer Ingelheim and Eli Lilly; a medicine to prevent strokes called Eliquis made by Pfizer and Bristol Myers Squibb; and a Novartis...
...Monday’s acquisition by Novartis of Seattle-based biotech firm Chinook Therapeutics for up to $3.5bn is a case in point....
...Vectura, which is run separately, has been investing in R&D, plans a new “inhalation centre of excellence” in Bristol, and hired a new boss from Novartis when its chief executive and finance director left...
...Founded by the Sandoz family, the business merged with Ciba-Geigy to create Novartis in 1996....
...Novartis exemplified a trend for diversification. Now, the Swiss giant is shedding non-core businesses....
...Haleon was created with consumer health assets from GSK, Pfizer and Novartis....
...Also at the ASCO conference, Novartis will share results from a trial using a novel targeted type of radiotherapy, known as radioligand, in metastatic castration-resistant prostate cancer, which significantly...
...AstraZeneca pulled out of this line of research in 2016, followed by Sanofi and Novartis in 2018....
...Then last summer, Novartis, which employed 300 people, put its plant up for sale. When the Novartis news reached BioNTech’s management, the company immediately expressed an interest....
...Germany’s BioNTech has agreed to buy a specialist production facility from Swiss pharma giant Novartis, which will allow it to deliver more than 500m additional doses of its Covid-19 vaccine next year....
...They developed cancer antibodies for Switzerland’s Novartis. Then BioNTech bought the plant to ramp up production of one of the handful of vaccines the world is counting on to end the pandemic....
...Dunoyer, AstraZeneca’s chief financial officer, told reporters on Saturday that Soliris’s “second-generation” successor Ultomiris was about 30 per cent cheaper, while Mr Soriot noted that Sanofi-Genzyme, Novartis...
...The generics unit of Novartis has admitted price-fixing as part of a $195m criminal settlement with the US Department of Justice that covered four conspiracies to rig drugs for patients suffering hypertension...
...Shannon Thyme Klinger, group general counsel at Swiss pharmaceutical group Novartis, is also heavily involved in ESG....
...BioNTech also acquired a manufacturing site in Marburg, Germany, in September from Swiss pharmaceutical group Novartis, which will increase its overall production capacity at some point next year....
...Strigini is a former president of Novartis Oncology and has also worked at several other drug companies....
...To boost supplies of antimalarials, generics manufacturers Teva and Novartis’ Sandoz have pledged to donate millions of doses to US hospitals....
...Research for a treatment has focused on either stemming viral replication or addressing an immune system overdrive known as cytokine storm, with big pharma groups including Roche, Novartis and Gilead testing...
...Paul Fehlner, former patent chief at Swiss drugmaker Novartis and now current chief executive of Revision Therapeutics, said pharma companies are more likely to make their drugs cheaper if there is a clear...
...Analysts at Morgan Stanley expect more price rises in the coming weeks because Amgen, Merck and Novartis have yet to announce their new prices....
...Former parent Novartis, the Swiss pharmaceuticals group, sighed with relief. Its underperforming subsidiary will fare better alone. Novartis has one fewer excuse for its own shortcomings....
...The two health charities invested alongside pharma giants Novartis and Johnson & Johnson, Medicxi said, of a fundraising that takes the total amount it has accumulated from investors over the past three...
...Shares in Novartis fell 1.5 per cent in after-hours trading to $88.98, while Amgen remained flat....
...Instead he was looking, over time, to make Sandoz “an autonomous unit within Novartis”....
International Edition